You are here

Home » Content

İLERİ YAŞTA ORTAYA ÇIKAN VASKÜLER ENDOTELYAL DİSFONKSİYONA SERUM HOMOSİSTEİN, LİPOPROTEİN (A) VE DİHİDROEPİANDROSTENEDiON SÜLFAT DÜZEYLERİNDEKİ DEĞİŞİKLİKLERİN KATKISI

IMPACT OF SERUM HOMOCYSTEIN, LIPOPROTEIN (A), AND DIHYDROEPIANDROSTENEDION SULPHATE LEVELS ON VASCULAR ENDOTHELIAL DYSFUNCTION IN THE ELDERLY

Journal Name:

  • İstanbul Tıp Fakültesi Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Objective: Vascular endothelial dysfunction (VED) is an important factor in the development of atherosclerosis. There are evidences about association of aging with VED. In this study, our aim is to identify if serum levels of homocystein, lipoprotein (a), apolipoproteins and dihydroepiandrostenedion sulphate interfere with vascular endothelial function in elderly. Materials and Methods: Sixty-seven hypertensive elderly patients and 35 hypertensive middle-aged patients were included into the study. Patients with diabetes and other cardiovascular risk factors were excluded. We compared flow mediated vasodilation of the brachial artery (BA) (FMD%) and carotid artery intima media thickness (CAIMT) of the patients with their ages, body mass indexes, systolic and diastolic blood pressures, serum lipids, glucose, creatinine, lipoprotein (a), homocystein and dihydroepiandrostenedion sulphate (DHEAS) levels. Results: FMD% was found inversely correlated with age and CAIMT (p<0.001, r = -0.317, p<0.001, r = -0.350). No significant relation was found between FMD% and serum homocystein, lipoprotein (a) and DHEAS levels. FMD% was found inversely correlated with baseline BA diameter (p = 0.014, r = -0.243) which was significantly higher in old-age group (4.06 ± 0.50 mm vs 3.73 ± 0.55 mm, p=0.005, t = 2.927). We correlated baseline BA diameter with FMD% in our old-age group to look for any possible relation between them independent from aging. Spearman’s correlation test revealed no association (p=0.286). Conclusion: It seems that changes in serum homocystein, lipoprotein (a) and DHEAS levels in advancing age do not cause significant VED in the elderly.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Vasküler endotelyal disfonksiyon (VED) ateroskleroz gelifliminde önemli bir etkendir. VED ile yafllanma aras›nda iliflki oldu¤una dair veriler mevcuttur. Bu çal›flmadaki amac›m›z, yafll›da ortaya ç›kan VED’e serum homosistein, lipoprotein (a) ve dihidroepiandrostenedion sülfat (DHEAS) düzeylerindeki de¤iflikliklerin katk›s›n›n olup olmad›¤›n›n araflt›r›lmas›d›r. Gereç ve yöntem: Tümü hipertansif olan 67 ileri yafll› ve 35 orta yafll› hasta çal›flmaya dahil edildi. Diyabet ve di- ¤er kardiyovasküler risk faktörleri olan hastalar çal›flmaya al›nmad›. Hastalar›n brakiyal arterlerinde oluflturulan geçici iskemi sonras› ortaya ç›kan vazodilatasyon (flow mediated dilation, FMD) düzeyi ve karotis arterlerinin intima media kal›nl›klar› (KAIMK), yafl, vücut kitle indeksi, sistolik ve diyastolik kan bas›nc›, serum lipid, glukoz, kreatinin, lipoprotein (a), homosistein ve DHEAS düzeyi ile karfl›laflt›r›ld›. Bulgular: FMD’nin yafl ve KAIMK ile ters orant›l› oldu¤u bulundu (p<0,001, r = -0,317, p<0,001, r = -0,350). FMD ile serum homosistein, lipoprotein (a) ve DHEAS de¤erleri aras›nda anlaml› bir iliflkiye rastlan›lmad›. D›fllanma kriterleri ve gruplar›n homojenizasyonu sonucu FMD ile hastalar›n di¤er biyoflimik parametreleri, VK‹ ve kan bas›nçlar› aras›nda anlaml› bir iliflki bulunmad›. FMD ile brakiyal arter bazal çap› birbirleriyle ters orant›l› bulundu (p=0,014, r = -0,243). Brakiyal arter bazal çap› yafll›larda anlaml› olarak daha geniflti (4,06 ± 0,50 mm’ye karfl› 3,73 ± 0,55 mm, p=0,005, t = 2,927). Bu nedenle ileri yaflta ortaya ç›kan VED’in bazal arter çap›ndaki de¤iflimle alakal› olup olmad›¤›n› anlamak için ileri yafl grubundaki hastalarda bu iliflki tekrar araflt›r›ld›. Spearman’s korelasyon testi anlaml› sonuç vermedi (p=0,286). Sonuç: Serum homosistein, lipoprotein (a) ve DHEAS düzeylerindeki de¤iflikliklerin, ileri yaflta ortaya ç›kan VED’e katk›da bulunmad›¤› düflünülmektedir
FULL TEXT (PDF): 
PDF icon arastirmax-ileri-yasta-ortaya-cikan-vaskuler-endotelyal-disfonksiyona-serum-homosistein-lipoprotein-dihidroepiandrostenedion-sulfat-duzeylerindeki-degisikliklerin-katkisi.pdf
  • 2
33-38
  • Turkish

REFERENCES

References: 

1. Aviv H, Khan MY, Skurnick J, Okuda K, Kimura M, Gardner J,
Priolo L, Aviv A. Age dependent aneuploidy and telomere length
of the human vascular endothelium. Atherosclerosis 2001;159:
281-287.
2. Brewer HB Jr. New features of the National Cholesterol Education
Program Adult Treatment Panel III. Lipid-lowering guidelines.
Clin Cardiol 2003; 26: 19-24.
3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ,
Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive
detection of endothelial dysfunction in children and adults at risk
of atherosclerosis. Lancet 1992; 340: 1111-1115.
4. Celermajer DS, Sorensen KE, Spielgelhalter DJ, Georgapoulos
D, Robinson J, Deanfield JE. Aging is associated with endothelial
dysfunction in healthy men before the age-related decline in
women. J Am Coll Cardiol 1994; 24: 471-476.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA,
Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella
EJ. Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure. National Heart,
Lung, and Blood Institute; National High Blood Pressure
Education Program Coordinating Committee. The Seventh Report
of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure. JAMA 2003;
289: 2560-2572.
6. Cosentino F, Osto E. Aging and endothelial dysfunction. Clin
Hemorheol Microcirc 2007; 37:143-147.
7. Deng YB, Wang XF, Le GR, Zhang QP, Li CL, Zhang YG. Evaluation
of endothelial function in hypertensive elderly patients
by high-resolution ultrasonography. Clin Cardiol 1999; 22: 705-
710.
8. Furumoto T, Fujii S, Saito N, Mikami T, Kitabatake A. Relationships
between brachial artery flow mediated dilation and carotid
artery intima-media thickness in patients with suspected
coronary artery disease. Jpn Heart J 2002; 43: 117-125.
9. Galle J, Bengen J, Schollmeyer P, Wanner C. Impairment of Endothelium-
Dependent Dilation in Rabbit Renal Arteries by Oxidized
Lipoprotein (a); Role of Oxygen-Derived Radicals. Circulation
1995; 92: 1582-1589.
Vascular endothelial dysfunction
‹stanbul T›p Fakültesi Dergisi Cilt / Volume: 71 • Say› / Number: 2 • Y›l/Year: 2008
- 37 -
10. Ginier P, Deedwania P. Lipoprotein(a) in patients who have noninsulin-
dependent diabetes with and without coronary artery disease.
Endocr Pract 1997; 3: 276-280.
11. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and
atherosclerosis. Insights and perspectives gained from studies of
human arteries. Arch Pathol Lab Med 1988; 112: 1018-1031.
12. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler
H. Role of oxidative stress in atherosclerosis. Am J Cardiol
2003; 91: 7-11.
13. Hartmann M, von Birgelen C, Mintz GS, van Houwelingen GK,
Eggebrecht H, Bose D, Wieneke H, Verhorst PM, Erbel R. Relation
between lipoprotein (a) and fibrinogen and serial intravascular
ultrasound plaque progression in left main coronary arteries.
J Am Coll Cardiol 2006; 48: 446-452.
14. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH,
Kostner GM. Lipoprotein Lp (a). Arisk factor for myocardial infarction.
Atherosclerosis 1988; 8: 398-401.
15. Kimura Y, Matsumoto M, Den YB, Iwai K, Munehira J, Hattori
H, Hoshino T, Yamada K, Kawanishi K, Tsuchiya H. Impaired
endothelial function in hypertensive elderly patients evaluated
by high resolution ultrasonography. Can J Cardiol 1999; 15:
563-568.
16. Liu J, Rosner MH. Lipid abnormalities associated with end-stage
renal disease. Semin Dial 2006; 19: 32-40.
17. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular
mechanism of endothelin regulation: implications for vascular
function. Circulation 1991; 84: 1457-1468.
18. Perrini S, Laviola L, Natalicchio A, Giorgino F. Associated hormonal
declines in aging: DHEAS. J Endocrinol Invest
2005;28:85-93.
19. Rosen EM, Mueller SN, Noveral JP, Levine EM. Proliferative
characteristics of clonal endothelial cell strains. J Cell Physiol
1981; 107: 123–137.
20. Saka B, Oflaz H, Erten N, Bahat G, Dursun M, Pamukcu B, Mercanoglu
F, Meric M, Karan MA. Non-invasive evaluation of endothelial
function in hypertensive elderly patients. Arch Gerontol
Geriatr 2005; 40: 61-71.
21. Salles-Montaudon N, Parrot F, Balas D, Bouzigon E, Rainfray
M, Emeriau JP. Prevalence and mechanisms of hyperhomocysteinemia
in elderly hospitalized patients. J Nutr Health Aging
2003; 7: 111-116.
22. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR,
Boerwhinkle E, Utermann G. Relation of serum lipoprotein (a)
concentration and apolipoprotein(a) phenotype to coronary heart
disease in patients with familial hypercholesterolemia. N Engl J
Med 1990; 322: 1494-1499.
23. Shirasaki Y, Su C, Lee TJ, Kolm P, Cline WH Jr, Nickols GA.
Endothelial modulation of vascular relaxation to nitrovasodilators
in aging and hypertension. J Pharmacol Exp Ther 1986; 239:
861-866.
24. Slunga L, Asplund K, Johnson O, Dahlen GH. Lipoprotein (a) in
a randomly selected 25-64 year old population: the Northern
Sweden Monica Study. J Clin Epidemiol 1993; 46: 617-624.
25. Stuhlinger MC, Stanger O. Asymmetric dimethyl-L-arginine
(ADMA): a possible link between homocyst(e)ine and endothelial
dysfunction. Curr Drug Metab 2005; 6: 3-14
26. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB,
Sudano I, Salvetti A. Aging and endothelial function in normotensive
subjects and patients with essential hypertension. Circulation
1995; 91: 1981-1987.
27. Vester B, Rasmussen K. High performance liquid chromatograpic
method for rapid and accurate determination of homocysteine
in plasma and serum. Eur J Clin Chem Clin Biochem 1991;
29: 549-554.
28. Woo KS, Sanderson JE, Sun YY, Chook P, Cheung AS, Chan
LT, Metreweli C, Lolin YI, Celermajer DS. Hyperhomocyst (e)
inemia is a risk factor for arterial endothelial dysfunction in humans.
Circulation 2000; 101: 116.

Thank you for copying data from http://www.arastirmax.com